Gene: AKR1B10
Official Full Name: aldo-keto reductase family 1 member B10provided by HGNC
Gene Summary: This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00943 | AKR1B10 Knockout cell line(Hep G2) | Human | AKR1B10 | 1:2~1:4 | Negative | Online Inquiry |
KO19912 | AKR1B10 Knockout cell line (HeLa) | Human | AKR1B10 | 1:3~1:6 | Negative | Online Inquiry |
KO19913 | AKR1B10 Knockout cell line (HCT 116) | Human | AKR1B10 | 1:2~1:4 | Negative | Online Inquiry |
KO19914 | AKR1B10 Knockout cell line (A549) | Human | AKR1B10 | 1:3~1:4 | Negative | Online Inquiry |
AKR1B10 Gene Knockout Cell Lines refer to a series of genetically engineered cell lines in which the AKR1B10 gene has been specifically disrupted. This product provides a valuable model for studying the functional roles of AKR1B10, an aldo-keto reductase implicated in various metabolic pathways, including the metabolism of therapeutic drugs and the development of certain diseases. By achieving knockout of the gene, researchers can isolate and examine the precise biological effects of its absence, aiding in the understanding of underlying mechanisms in health and disease.
The primary function of AKR1B10 involves catalyzing the reduction of aldehydes and ketones, which plays a critical role in detoxifying oxidized lipids and processing drugs. The knockout of this gene allows researchers to delve into topics such as metabolic drug-drug interactions, the biochemical pathways of cancer, and diabetic complications, providing insight into potential therapeutic strategies.
The scientific importance of AKR1B10 Gene Knockout Cell Lines extends across multiple domains, including cancer research, pharmacology, and toxicology. By utilizing these knockout models, researchers can gain an in-depth understanding of the physiological roles that AKR1B10 plays in drug metabolism and disease progression. Additionally, these models can facilitate the identification of new biomarkers and drug targets, increasing their utility in clinical settings.
When compared to wild-type cell lines or alternative models, AKR1B10 Gene Knockout Cell Lines offer distinct advantages, including the specificity of gene deletion that eliminates confounding effects, improved reproducibility in experimental outcomes, and the ability to model disease states that reflect the absence of this crucial enzyme.
For researchers and clinicians involved in drug metabolism studies or disease mechanism investigations, these cell lines represent an invaluable resource, allowing for precise experimentation that can translate findings into clinical applications. Our company prides itself on developing high-quality, reliable biological products backed by extensive expertise in genetic engineering and cell biology, ensuring that you have the tools necessary to advance your research effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.